KMUP-1 attenuates serum deprivation-induced neurotoxicity in SH-SY5Y cells: roles of PKG, PI3K/Akt and Bcl-2/Bax pathways

Toxicology. 2010 Jan 31;268(1-2):46-54. doi: 10.1016/j.tox.2009.11.021. Epub 2009 Dec 3.

Abstract

Aging populations with neurodegenerative disorders will gradually become a greater problem for society. Serum deprivation-induced cell death is recognized as one of the standard models for the study of neurotoxicity. Increasing evidence indicates that cGMP/PKG pathway may play a rescue role in serum deprivation-induced toxicity. The aim of this study was to investigate protective effects of KMUP-1, an enhancer of cGMP/PKG signaling on serum deprivation-induced neurotoxicity in SH-SY5Y neuroblastoma cells. Under normal serum condition, KMUP-1 enhanced protein expression of nNOS, PKG and sGCalpha1, increased intracellular cyclic GMP level, and attenuated PDE5 expression. KMUP-1 also increased expression of BDNF and Bcl-2, but it did not affect Bax expression. The phosphorylation of Akt and CREB induced by KMUP-1 was inhibited by tyrosine kinase (TrK) inhibitor K252a and phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002, respectively. Under serum deprivation condition, flow cytometric analysis using Annexin V showed KMUP-1 increased cell viability, but lacked protective effects in the presence of nitric oxide synthase inhibitor l-NAME, PKG inhibitor Rp-8-pCPT-cGMPS or LY294002. KMUP-1 not only enhanced expression of nNOS, sGCalpha1, PKG, p-CREB, p-Akt and Bcl-2, but also attenuated Bax expression in serum deprivation-treated cultures. In conclusion, cGMP/PKG, PI3K/Akt/CREB and Bcl-2/Bax signals play critical roles in the neuroprotective effects of KMUP-1 on serum deprivation-induced toxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Brain-Derived Neurotrophic Factor / metabolism
  • Cell Line, Tumor
  • Culture Media, Serum-Free*
  • Cyclic AMP / pharmacology
  • Cyclic GMP-Dependent Protein Kinases / metabolism*
  • Cyclic Nucleotide Phosphodiesterases, Type 5 / metabolism
  • Humans
  • Nervous System / drug effects*
  • Nervous System / enzymology
  • Nervous System / metabolism
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type I / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Piperidines / pharmacology*
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Up-Regulation / drug effects
  • Xanthines / pharmacology*
  • bcl-2-Associated X Protein / metabolism*

Substances

  • Brain-Derived Neurotrophic Factor
  • Culture Media, Serum-Free
  • Piperidines
  • Xanthines
  • bcl-2-Associated X Protein
  • KMUP 1
  • Nitric Oxide
  • Cyclic AMP
  • Nitric Oxide Synthase Type I
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Cyclic GMP-Dependent Protein Kinases
  • Cyclic Nucleotide Phosphodiesterases, Type 5